Landec Corporation (LNDC) Social Stream
Featured Post From StockTwits About LNDC
$HRTX $LNDCINDpharmD, published July 29, 2021
Contract manufacturer for Zynrelef Landec Corp conference call mentioned Heron Therapeutics and zynrelef multiple times. They are designating 32M for fiscall 22 in CAPEX to increase production abilities from 10 million units to 32 million units per year over next 5yrs to meet expected demands. (For all products).
Quote from the call:
"We had a very exciting fourth quarter with the highlight being our CMO partner, Heron Therapeutics, FDA approval for its Zen relief product, an important new therapy for treating certain post-surgical pain. The approval showcases the support that life cause world-class quality systems in manufacturing engineering excellence provides to our partners.
We now look forward to continuing to work with Heron on commercializing Zen relief over the course of our fiscal 2022, which includes the continued process optimization and scale up of our commercial manufacturing process that will support this important product."
What Else are LNDC Traders Talking About?
Other tickers frequently mentioned alongside LNDC is HRTX.